Biotrend Cevre (Turkey) Performance
| BIOEN Stock | TRY 17.85 0.15 0.85% |
Biotrend Cevre has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biotrend Cevre are expected to decrease at a much lower rate. During the bear market, Biotrend Cevre is likely to outperform the market. Biotrend Cevre ve right now shows a risk of 2.53%. Please confirm Biotrend Cevre ve sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Biotrend Cevre ve will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biotrend Cevre ve are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong forward indicators, Biotrend Cevre is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 101.8 M |
Biotrend |
Biotrend Cevre Relative Risk vs. Return Landscape
If you would invest 1,770 in Biotrend Cevre ve on September 23, 2024 and sell it today you would earn a total of 15.00 from holding Biotrend Cevre ve or generate 0.85% return on investment over 90 days. Biotrend Cevre ve is generating 0.0445% of daily returns and assumes 2.5308% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Biotrend, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biotrend Cevre Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotrend Cevre's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biotrend Cevre ve, and traders can use it to determine the average amount a Biotrend Cevre's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0176
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIOEN |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biotrend Cevre is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotrend Cevre by adding it to a well-diversified portfolio.
Biotrend Cevre Fundamentals Growth
Biotrend Stock prices reflect investors' perceptions of the future prospects and financial health of Biotrend Cevre, and Biotrend Cevre fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotrend Stock performance.
| Return On Equity | 0.0978 | |||
| Return On Asset | 0.0657 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.22 % | |||
| Price To Earning | 114.34 X | |||
| Revenue | 427.7 M | |||
| EBITDA | 84.88 M | |||
| Cash And Equivalents | 25.91 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 696.56 M | |||
| Debt To Equity | 2.09 % | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | (326.18 M) | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 1.83 B | |||
About Biotrend Cevre Performance
By evaluating Biotrend Cevre's fundamental ratios, stakeholders can gain valuable insights into Biotrend Cevre's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biotrend Cevre has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotrend Cevre has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Biotrend Cevre Ve Enerji Yatirimlari Anonim Sirketi engages in the solid waste management and energy production activities in Turkey. The company was founded in 2017 and is based in Istanbul, Turkey. BIOTREND CEVRE is traded on Istanbul Stock Exchange in Turkey.Things to note about Biotrend Cevre ve performance evaluation
Checking the ongoing alerts about Biotrend Cevre for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biotrend Cevre ve help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotrend Cevre ve has accumulated 696.56 M in total debt with debt to equity ratio (D/E) of 2.09, implying the company greatly relies on financing operations through barrowing. Biotrend Cevre ve has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotrend Cevre until it has trouble settling it off, either with new capital or with free cash flow. So, Biotrend Cevre's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotrend Cevre ve sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotrend to invest in growth at high rates of return. When we think about Biotrend Cevre's use of debt, we should always consider it together with cash and equity. | |
| Biotrend Cevre ve has accumulated about 25.91 M in cash with (326.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 67.0% of Biotrend Cevre shares are held by company insiders |
- Analyzing Biotrend Cevre's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotrend Cevre's stock is overvalued or undervalued compared to its peers.
- Examining Biotrend Cevre's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotrend Cevre's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotrend Cevre's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biotrend Cevre's stock. These opinions can provide insight into Biotrend Cevre's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biotrend Stock analysis
When running Biotrend Cevre's price analysis, check to measure Biotrend Cevre's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotrend Cevre is operating at the current time. Most of Biotrend Cevre's value examination focuses on studying past and present price action to predict the probability of Biotrend Cevre's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotrend Cevre's price. Additionally, you may evaluate how the addition of Biotrend Cevre to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |